97 related articles for article (PubMed ID: 17094920)
1. [Research progression on complement regulatory proteins CD46, CD55, and CD59 in tumor immunotherapy].
Qin C; Cai XY
Ai Zheng; 2006 Nov; 25(11):1450-3. PubMed ID: 17094920
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ
Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
[TBL] [Abstract][Full Text] [Related]
3. [The role of membrane glycoproteins CD46, CD55 and CD59 in protection of tumor cells against complement lysis].
Wojnicz D; Bar J; Jankowski S
Postepy Hig Med Dosw; 2002; 56(5):603-16. PubMed ID: 12587428
[TBL] [Abstract][Full Text] [Related]
4. Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59.
Ziller F; Macor P; Bulla R; Sblattero D; Marzari R; Tedesco F
Eur J Immunol; 2005 Jul; 35(7):2175-83. PubMed ID: 15971270
[TBL] [Abstract][Full Text] [Related]
5. Systematic immunohistochemical analysis of the expression of CD46, CD55, and CD59 in colon cancer.
Shang Y; Chai N; Gu Y; Ding L; Yang Y; Zhou J; Ren G; Hao X; Fan D; Wu K; Nie Y
Arch Pathol Lab Med; 2014 Jul; 138(7):910-9. PubMed ID: 24978917
[TBL] [Abstract][Full Text] [Related]
6. Immunization against tumor cell surface complement-regulatory proteins.
Durrant LG; Spendlove I
Curr Opin Investig Drugs; 2001 Jul; 2(7):959-66. PubMed ID: 11757799
[TBL] [Abstract][Full Text] [Related]
7. CD55 and CD59 protein expression by Apodemus (field mice) sperm in the absence of CD46.
Clift LE; Dvorakova-Hortova K; Frolikova M; Andrlikova P; Salman S; Stopka P; Flanagan BF; Johnson PM
J Reprod Immunol; 2009 Jul; 81(1):62-73. PubMed ID: 19501411
[TBL] [Abstract][Full Text] [Related]
8. Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease.
Simpson KL; Jones A; Norman S; Holmes CH
Am J Pathol; 1997 Nov; 151(5):1455-67. PubMed ID: 9358772
[TBL] [Abstract][Full Text] [Related]
9. Complement regulatory proteins in normal human esophagus and esophageal squamous cell carcinoma.
Shimo K; Mizuno M; Nasu J; Hiraoka S; Makidono C; Okazaki H; Yamamoto K; Okada H; Fujita T; Shiratori Y
J Gastroenterol Hepatol; 2004 Jun; 19(6):643-7. PubMed ID: 15151618
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction.
Saifuddin M; Hedayati T; Atkinson JP; Holguin MH; Parker CJ; Spear GT
J Gen Virol; 1997 Aug; 78 ( Pt 8)():1907-11. PubMed ID: 9266986
[TBL] [Abstract][Full Text] [Related]
11. Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells.
Moutabarrik A; Nakanishi I; Namiki M; Hara T; Matsumoto M; Ishibashi M; Okuyama A; Zaid D; Seya T
Lymphokine Cytokine Res; 1993 Jun; 12(3):167-72. PubMed ID: 7688580
[TBL] [Abstract][Full Text] [Related]
12. Expression and modulation of RPE cell membrane complement regulatory proteins.
Yang P; Tyrrell J; Han I; Jaffe GJ
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3473-81. PubMed ID: 19168900
[TBL] [Abstract][Full Text] [Related]
13. The complement regulatory proteins CD55 (decay accelerating factor) and CD59 are expressed on the inner acrosomal membrane of human spermatozoa as well as CD46 (membrane cofactor protein).
Cummerson JA; Flanagan BF; Spiller DG; Johnson PM
Immunology; 2006 Jul; 118(3):333-42. PubMed ID: 16827894
[TBL] [Abstract][Full Text] [Related]
14. Expression of complement system regulatory molecules in the endometrium of normal ovulatory and hyperstimulated women correlate with menstrual cycle phase.
Nogawa Fonzar-Marana RR; Ferriani RA; Soares SG; Cavalcante-Neto FF; Teixeira JE; Barbosa JE
Fertil Steril; 2006 Sep; 86(3):758-61. PubMed ID: 16831436
[TBL] [Abstract][Full Text] [Related]
15. Adeno-associated virus mediated delivery of an engineered protein that combines the complement inhibitory properties of CD46, CD55 and CD59.
Leaderer D; Cashman SM; Kumar-Singh R
J Gene Med; 2015; 17(6-7):101-15. PubMed ID: 25917932
[TBL] [Abstract][Full Text] [Related]
16. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA
Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
[TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of siRNA using transferrin-coupled lipoplexes specifically sensitizes CD71 high expressing malignant cells to antibody-mediated complement attack.
Cinci M; Mamidi S; Li W; Fehring V; Kirschfink M
Target Oncol; 2015 Sep; 10(3):405-13. PubMed ID: 25395366
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro.
Geis N; Zell S; Rutz R; Li W; Giese T; Mamidi S; Schultz S; Kirschfink M
Curr Cancer Drug Targets; 2010 Dec; 10(8):922-31. PubMed ID: 20879979
[TBL] [Abstract][Full Text] [Related]
19. Cell-surface density of complement restriction factors (CD46, CD55, and CD59): oral squamous cell carcinoma versus other solid tumors.
Ravindranath NM; Shuler C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Feb; 103(2):231-9. PubMed ID: 17234541
[TBL] [Abstract][Full Text] [Related]
20. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.
Brasoveanu LI; Altomonte M; Fonsatti E; Colizzi F; Coral S; Nicotra MR; Cattarossi I; Cattelan A; Natali PG; Maio M
Lab Invest; 1996 Jan; 74(1):33-42. PubMed ID: 8569195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
